|
37 Innovation needs
a new approach A new approach to innovation
in the NHS is needed to enable pharmacy to provide the range of clinical
services to which it aspires, according to organisations that represent
community pharmacy owners
PJ 2007;279:37
Full Text
37 MPs back pharmacist role in screening Pharmacists should be involved in the Government’s plans to expand screening services, Howard Stoate (Lab, Dartford) said in a House of Commons debate on preventive health services last week
PJ 2007;279:37
Full Text
37NPA seeks second chief in a year following White’s abrupt departure Alison
White has stepped down as chief executive of the National Pharmacy Association,
the NPA confirmed this week
PJ 2007;279:37
Full Text
38 PSNC wants pharmacy to be
main provider for minor ailment care Pharmacy should
be the provider of choice for patients with minor ailments and those requiring
certain community-based healthcare services, such as screening and monitoring
of long-term conditions, the Pharmaceutical Services Negotiating Committee believes
PJ 2007;279:38
Full Text
38 GPs prescribe too many branded medicines At least £200m a year is wasted on NHS medicines in England because GPs continue to prescribe too high a proportion of branded medicines rather than cheaper generic versions, the Public Accounts Committee reported this week
PJ 2007;279:38
Full Text
38 Society calls on pharmacy schools to host
PhD awards Pharmacy schools in the UK are being
encouraged by the Royal Pharmaceutical Society to submit applications to host
the 2009 Academic Excellence Awards, which allow pharmacy graduates to undertake
a PhD
PJ 2007;279:38
Full Text
38 EPS update Up
to 24 per cent of prescriptions are now prescribed via the electronic prescription
service in England but less than 1 per cent are being dispensed using the service,
reports the Pharmaceutical Services Negotiating Committee
PJ 2007;279:38
Full Text
38 MUR uptake increasing Uptake
of medicines use reviews is increasing
PJ 2007;279:38
Full Text
38 Virgin enters health arena Virgin Group is to open the first of six healthcare centres this year under a new brand — Virgin Healthcare
PJ 2007;279:38
Full Text
39 Pharmacist should almost
always be on premises Pharmacies should have a pharmacist present for the vast majority of the time they are open and this should be specified in the responsible pharmacist regulations, according to the National Pharmacy Association response to the Government’s consultation on the subject, which closes this week
PJ 2007;279:39
Full Text
39 Concept of responsible pharmacist is flawed
and too prescriptive The responsible pharmacist concept is flawed and unnecessarily prescriptive and criminalising, according to Noel Baumber, a non-executive director of the Independent Pharmacy Federation. In his opinion “the cure is worse than the disease”
PJ 2007;279:39
Full Text
39 PDA Union election results announced The Pharmacists’ Defence Association has announced results from its recent PDA Union elections
PJ 2007;279:39
Full Text
39 PEC membership guide Gaining
professional executive committee (PEC) membership is the focus of a guide published
jointly by national pharmacy bodies this week. The guide was developed in response
to the new constitution and format for primary care trust PECs put in place last
year
PJ 2007;279:39
Full Text
40 Training of paediatric prescribers
by pharmacists needs evaluating Paediatric pharmacists
are playing a significant role in teaching doctors about prescribing for children,
but more needs to be done to evaluate the effectiveness of this training, according
to an article published online
PJ 2007;279:40
Full Text
40 Statins suggested for all patients with diabetes Statin
therapy reduces the risk of major vascular events in a wide range of patients
with diabetes, including those with no history of vascular disease, and the benefits
are similar to those for people without diabetes, a recently published study
reveals
PJ 2007;279:40
Full Text
40 Etanercept works for paediatric psoriasis Tumour
necrosis factor inhibitor etanercept has been shown to reduce the severity of
plaque psoriasis in children and adolescents with moderate to severe disease
in a recently published study
PJ 2007;279:40
Full Text
40 Possible cardiac risks with calcium identified Use
of calcium supplements is associated with an increased likelihood of cardiovascular
events for post-menopausal women, according to a study published online this
week
PJ 2007;279:40
Full Text
41 Guidance on sexual boundaries
launched by CHRE Guidance on keeping appropriate
sexual boundaries between healthcare professionals and patients has been published
by the Council for Healthcare Regulatory Excellence
PJ 2007;279:41
Full Text
41 Influenza vaccine orders in Scotland must
be placed with three sources to maintain supply Community
pharmacists in Scotland must order influenza vaccines from at least three different
sources, according to guidance published this week
PJ 2007;279:41
Full Text
41 Combination inhaler accepted for use within
NHS Scotland A new combination inhaler containing beclometasone 100µg and formoterol 6µg has been accepted for use within NHS Scotland
PJ 2007;279:41
Full Text
41 CPP deadline extended Community
pharmacists in Scotland now have until 15 March 2008 to claim for phase 2 contract
preparation payments (CPP)
PJ 2007;279:41
Full Text
41 ETP leaflets All
pharmacies and GP surgeries in Scotland will receive NHS patient information
leaflets about the electronic transfer of prescriptions this month
PJ 2007;279:41
Full Text
41 eMAS update Updated
questions and answers about the minor ailment service in Scotland have been published
on the Scottish community pharmacy contract website
PJ 2007;279:41
Full Text
42 Patient-controlled fentanyl
device requires no needle A needle-free, patient-controlled
device for postoperative pain relief was launched in the UK this week. Ionsys,
a credit card-sized device that contains a gel-based reservoir of ionised fentanyl,
is licensed for the management of moderate-to-severe postoperative pain
PJ 2007;279:42
Full Text
42 New drug class for HIV patients with highly
drug-resistant disease People with HIV who have
become resistant to existing antiretroviral medicines may be suitable for treatment
with raltegravir, the first of a new class of antiretroviral medicines known
as integrase inhibitors
PJ 2007;279:42
Full Text
42 NICE should not assess cost-effectiveness
for all new medicines, industry body believes Uptake
of innovative medicines will not be improved by assessing the cost-effectiveness
of all medicines at launch, pharmaceutical industry representatives believe
PJ 2007;279:42
Full Text |
The
Pharmaceutical Journal